Turkey Biosimilar Market Report 2026-2034: Size, Trends and Growth Opportunities
Turkey's biosimilar sector is emerging as one of the most closely watched segments within the country's pharmaceutical industry, supported by rising healthcare expenditure, an expanding base of patients requiring biologic therapies, and strong government emphasis on reducing the cost burden of complex medicines. Turkey biosimilar market size reached USD 422.0 Million in 2025. The market is...
0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
Προωθημένο

Download Palxup Now

Get Mobile Palxup on Play Store

Προωθημένο
Προωθημένο
Προωθημένο